About Duct Occluder
Add to Cart the new Amplatzer Duct Occluder-a top-drawer solution for transcatheter occlusion of Patent Ductus Arteriosus (PDA). Manufactured with immaculate precision using Nitinol alloy, this world-class device boasts flexible, self-expandable design and radiopaque markers for absolute positioning accuracy. Delivered via catheter under fluoroscopic guidance, it ensures minimally invasive, manual placement for both pediatric and adult cardiology patients. Competitively priced, it features sterile, single-use blister packaging with product information, CE Mark, and US FDA Approval (check region). Resistant to corrosion and fatigue, it's biocompatible with a typical 3-5 year shelf life.
Special Features and Application Sites of Duct Occluder
The Amplatzer Duct Occluder is specifically designed for closure of Patent Ductus Arteriosus (PDA), utilizing radiopaque markers and a flexible, self-expandable mushroom or double-disc shape for impeccable accuracy. Suitable for both pediatric and adult cardiology patients, it's used primarily in cardiac catheterization labs. Its special features include MRI compatibility, corrosion resistance, and lightweight nitinol construction, ensuring seamless performance in minimally invasive cardiac interventions across specialty hospitals and heart care centers.
Domestic Market Reach, Delivery Timeline, and Packaging
Our Duct Occluder dominates the domestic mar, with a strong presence in India as an exporter, supplier, and trader. The proposal amount is structured with competitive pricing, catering to bulk and single unit buyers alike. Expect prompt transportation, with standard delivery times optimized for urgent cardiac procedures. Each device is securely blister-packed, including comprehensive product information and sterile handling instructions, further ensuring safety and reliability from shipment to site of application.
FAQ's of Duct Occluder:
Q: How is the Amplatzer Duct Occluder delivered and positioned during a cardiac procedure?
A: The Amplatzer Duct Occluder is delivered via a catheter under fluoroscopic guidance, allowing manual placement with immaculate precision. Radiopaque markers facilitate optimal positioning for successful closure of the Patent Ductus Arteriosus (PDA).
Q: What are the main benefits of using a Nitinol-based occluder?
A: Nitinol construction provides excellent flexibility, superior fatigue and corrosion resistance, and consistent self-expansion, resulting in reliable and biocompatible closure of cardiac defects with minimal complications.
Q: Where is the primary site of application for this Duct Occluder?
A: This duct occluder is mainly used in cardiac catheterization laboratories and specialized cardiovascular hospitals for both pediatric and adult patients requiring PDA closure.
Q: When should the device be replaced or restocked by hospitals?
A: Hospitals should monitor the shelf life, typically 3 to 5 years from the date of manufacture, and replace or restock before expiry to maintain sterility and optimal device integrity.
Q: What packaging and regulatory certifications does the Amplatzer Duct Occluder carry?
A: Each device is packaged in a sterile blister pack with detailed instructions. It is CE marked and has US FDA approval, varying by region, ensuring world-class quality and compliance.
Q: How does the duct occluder function in PDA closure procedures?
A: The device is manually deployed via catheter to precisely occlude abnormal blood flow in the PDA, effectively sealing the defect to restore normal cardiovascular function.